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DNA double-strand break repairTerminally-differentiated cells cease to proliferate and acquire speciﬁc sets of expressed genes and functions
distinguishing them from less differentiated and cancer cells. Mature granulocytes show lobular structure of
cell nuclei with highly condensed chromatin in which HP1 proteins are replaced by MNEI. These structural
features of chromatin correspond to low level of gene expression and the loss of some important functions
as DNA damage repair, shown in this work and, on the other hand, acquisition of a new speciﬁc function
consisting in the release of chromatin extracellular traps in response to infection by pathogenic microbes.
Granulocytic differentiation is incomplete in myeloid leukemia and is manifested by persistence of lower
levels of HP1γ and HP1β isoforms. This immaturity is accompanied by acquisition of DDR capacity allowing
to these incompletely differentiated multi-lobed neutrophils of AML patients to respond to induction of DSB
by γ-irradiation. Immature granulocytes persist frequently in blood of treated AML patients in remission.
These granulocytes contrary to mature ones do not release chromatin for NETs after activation with phorbol
myristate-12 acetate-13 and do not exert the neutrophil function in immune defence. We suggest therefore
the detection of HP1 expression in granulocytes of AML patients as a very sensitive indicator of their matu-
ration and functionality after the treatment. Our results show that the changes in chromatin structure under-
lie a major transition in functioning of the genome in immature granulocytes. They show further that
leukemia stem cells can differentiate ex vivo to mature granulocytes despite carrying the translocation
BCR/ABL.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
To understand development of leukemia, it is important to know
how changes of chromatin structure are orchestrated during the
CD34+ stem cells differentiation and how they correlate with chro-
matin functions in normal differentiated cells and leukemia condi-
tions. New blood cells of different cell lineages are formed from
bone marrow hematopoietic stem cells (HSCs), which provide a con-
stant supply of blood cells throughout life. HSCs show considerable
plasticity and can reprogram their gene expression in response to sig-
nals produced by a combination of cytokines giving rise to different
clones of blood cells with speciﬁc functions. For example, granulocyt-
ic colony stimulating factor (G-CSF) is used to mobilize HSCs todemy of Sciences of the Czech
ic. Tel.: +420 541517165; fax:
rights reserved.peripheral blood for using peripheral blood stem cells (PBSC) in
transplantation regimes [1] and also to stimulate granulocytic differ-
entiation of HSCs in vitro. HSCs express several speciﬁc antigens on
the surface (particularly CD34+) and do not express lineage antigens
of differentiated cells (Lin– cells) [2].
Terminal cell differentiation involves a large-scale chromatin re-
modeling that turnsmost of the open euchromatin into condensed het-
erochromatin [3]. During this process, most genes that are required for
cell “housekeeping” functions acquire heterochromatin organization
and become repressed [4,5]. Heterochromatin is associatedwith certain
types of histone lysine methylation (e.g. at histone H3 lysines 9 and 27
and histone H4 lysine 20), which have a role in preserving heterochro-
matin structure and rendering histones less susceptible to activatory
modiﬁcations [6]. The preservation and spreading of heterochromatin
is mediated through the direct interaction of dimethylated histone H3
at lysine 9 (H3K9me2) with heterochromatin protein 1 (HP1) [6–8].
However, recent data show that the HP1 is dramatically reduced inma-
ture erythrocytes, lymphocytes and especially granulocytes [9–13]. On
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Fig. 2. CD34+ cells isolated from the bone marrow of a CML patient. Cells were ﬁxed by paraformaldehyde and submitted to co-immunodetection with antibodies derived from a
rabbit and a mouse to HPlα and HP1β; HP1γ, and MNEI; cMYC and H3K9me2. Total images of nuclei (composed from 40 slices of 0.2 μm thin) were obtained by the confocal mi-
croscope Leica DM RXA.
769E. Lukášová et al. / Biochimica et Biophysica Acta 1833 (2013) 767–779the other hand, it was shown that the level of H3K9me2 in mature
granulocytes is high [14] despite this epitope being immunochemically
undetectable [13] due to its weak exposure in the tightly condensed
chromatin. Nevertheless, a distinct level of H3K9me2 was detected by
immunoﬂuorescence in neutrophils of patients in the chronic phase of
chronic myeloid leukemia (CML) without detectable HP1 proteins.
Dimethylated histone became more easily detected in granulocytes of
CML patients in blast crisis and in acute myeloid leukemia (AML)
[13,14] where it was also accompanied by high levels of HP1 proteins.
The accessibility of the histone H3K9 for immunodetection indicates
an incomplete chromatin condensation of AML neutrophils, also fre-
quent in patients in remission.
The leukocytes of healthy donors, chronic CML and AML patients ex-
press a nucleo-cytoplasmic serpin MNEI (monocyte neutrophil elastase
inhibitor) thatwas proposed to replace HP1 during the terminalmyeloid
differentiation [14] similar to the closely related serpin MENT (myeloid
and erythroid nuclear termination stage-speciﬁc protein) expressed in
terminally differentiated avian granulocytes [15,16]. MNEI accumulates
in the nuclei of neutrophils at one of the late stage of their maturation
[17]. The presence of HP1 proteins in multi-lobed nuclei of neutrophils
of leukemic individuals and decreased MNEI thus indicate that chroma-
tin of these cells is not completely condensed and that these cells are
immature.Fig. 1. CD34+ cells isolation and ex vivo differentiation. (A) Flow cytometric data of CD34+ ce
after immunomagnetic separation: (A-a, A-b) ﬂow cytometric analysis of bone marrow of a C
side scatter, (A-b) CD34+ labeled with FITC vs. side scatter. (A-c) Flow cytometric analysis o
ysis of PBSC from a healthy donor before immunomagnetic selection. (A-d) Forward scatte
analysis of CD34+ purity (94%) after immunomagnetic selection. (B, C) Progress of HSC diff
fraction of CD34+ mononuclear cells in serum-free (black line, squares) and serum-supplem
(C) cells from PBSC of a healthy donor. Insets (Bii, Cii): CD16 expression after 14-day culture
expression, nuclear morphology and epigenetic markers of chromatin structure during ex
time-axis indicate the appearance of the particular changes (described in the boxes).To determine whether elimination of HP1 proteins, increase of
nuclear MNEI and chromatin condensation occur coordinately dur-
ing granulopoiesis of normal and leukemic stem cells or possibly re-
ﬂect the presence of genetic translocation between BCR-ABL genes
in these last cells, we followed ex vivo differentiation of CD34+
cells isolated from the bone marrow of patients with chronic-
phase CML with complete hematological response to imatinib
mesylate (Glivec), the PBSCs of healthy donors and from patients
with non-Hodgkin's lymphoma (NHL). In patients with NHL, the dif-
ferentiation into granulocytic lineage should not be affected, thus
these samples served as an additional control for comparison with
the CML sample.
Next to changes in chromatin structure,we focused on functional dif-
ferences between terminally differentiated granulocytes from healthy
donors and incompletely differentiated blood cells taken from AML pa-
tients. Due to the stable repression of many genes accompanied by pro-
found changes in chromatin structure, differentiated cells dramatically
change their metabolic activity and responsiveness to many signals;
however, theymostly preserve the ability tomaintain thegenome integ-
rity including the detection, signaling and repair of DNA damage. Here
we studied differentiation-dependent changes in the DNA damage re-
sponse (DDR) induced by one of the most profound damages to the ge-
nome the interruption of both DNA strands called double-strand breakll fractions from bone marrow of a CML patient and PBSC of a healthy donor before and
ML patient before immunomagnetic selection of CD34+ cells. (A-a) Forward scatter vs.
f CD34+ purity (92%) after immunomagnetic selection. (A-d, A-e) ﬂow cytometric anal-
r vs. side scatter, (A-e) CD34+ labeled with FITC vs. side scatter. (A-f) Flow cytometric
erentiation (measured as decrease in CD34 expression) during culture of the enriched
ented (blue line, triangles) medium: (B) Cells from the bone marrow of a CML patient;
in serum-free medium. (D) A scheme showing the timing of the changes in the antigens
vivo differentiation of CD34+ cells to granulocytes. The arrows emanating from the
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H2AX is phosphorylated on serine 139 (γH2AX) by ATM kinase in the
proximity of DSBs. This phosphorylation spreads up to the distance of
about 2Mbp of DSB ﬂanking chromatin forming thus foci known as
IRIFs [18–20]. These foci are generally used for the detection of DSBs.
Many repair proteins including sensors, transducers and effectors are
rapidly attached to γH2AX to repair this damage. MDC1, NBS1, MRE11,
RAD50, ATM kinase, 53BP1 colocalize with γH2AX as the ﬁrst and
their presence in IRIF indicates the ongoing process of DSB repair [20].
Global chromatin condensation was shown to inhibit DDR [21] while
HP1 proteins may play a positive role in DDR [22].
We examinedwhether theDDR induced by ionizing radiation is pre-
served in terminally differentiated mature granulocytes that have con-
densed chromatin, a short life span, are capable to unravel neutrophil
extracellular traps (NETs) to capture and kill microbes [23], but lack
HP1 [13]. This ability was examined also in the immature granulocytes
and incompletely differentiated precursors emerging in peripheral
blood of leukemic individuals before the disease treatment as well as
in remission. In addition, we investigated whether the ability of mature
neutrophils to release chromatin NETs after activation [23–28] is also
preserved by immature neutrophils of AML patients expressing HP1γ.
We show that CML stem cells can differentiate ex vivo to mature
granulocytes despite the presence of the BCR/ABL translocation and
that mature granulocytes from healthy donors neither express DNA
repair proteins nor undergo proper DDR contrary to immature leuke-
mia granulocytes. Immature neutrophils of AML patients are not able
to release chromatin into neutrophil extracellular traps (NETs) after
activation with phorbol 12-myristate 13-acetate (PMA) and thus ex-
ecute the principal function of neutrophils. Taken together, a tight
correlation between chromatin structure and cell function has been
observed giving an interesting picture of mechanisms governing
granulocytic differentiation.
2. Material and methods
2.1. Cells
Mature granulocytes and mononuclear cells (lymphocytes and
monocytes) were isolated from peripheral blood as described earlier
[13]. The resulting cell population contained more than 95% of mature
neutrophils as assessed by microscopy analysis. Immature neutrophils
were isolated by the same procedure from the peripheral blood of pa-
tients with acute myeloid leukemia (AML). The informed consent of
all blood donors was obtained.
2.2. Patients
The peripheral blood was obtained from ten AML patients from
the Hemato-Oncology Clinic of Faculty Hospital in Brno–Bohunice
and three patients from the Hemato Oncology Clinic of Faculty Hospi-
tal in Olomouc. The causal mutations of the disease were different at
these patients. Patients were divided into 2 groups according to pres-
ence or absence of HP1 proteins in their neutrophils isolated from the
peripheral blood without respect to genetic changes.Fig. 3. Changes in the presence of HP1α, β, cMYC, dimethylated H3K9 (A, B, C), HP1γ and MN
of a CML patient in IMDM completed with FCS. (A, D) Images of DNA inside the cell nuclei (
process. (A) The levels of HP1α and β decreased on day 10 and disappeared from the nucle
tectable until day 18 of the process in neutrophils originated from CD34+ cells of the CML
grated optical density (IOD) express levels of speciﬁc proteins during differentiation of CD34
nuclei per speciﬁc time. Attached cells preserved their natural shape and were not deform
speciﬁc time of observation and given in IOD. High s.d. show differences in IOD of individual
connected with different stages of cells differentiation on the slide. A statistically signiﬁcan
Student's t-test: *Pb0.05, **Pb0.01. (D) The level of MNEI in cells at given times of the differ
the nucleus and cytoplasm expressed as % of the mean value of IOD measured in the centra
each time. The proportion of the IOD in the nucleus and the cytoplasm was calculated from
signiﬁcantly lower (Pb0.05) than in the nucleus from day 6 and decreased to a negligible
function in order to allow the ﬁgure printing.2.3. Cell irradiation
Cells were irradiated with 3 Gy of γ-rays (60Co, 1 Gy/min) in RPMI
medium with 10% fetal calf serum (FCS) immediately after isolation
and maintained in this medium for next 30 min before ﬁxation or
RNA and protein isolation.
2.4. Hemopoietic stem cells (HSCs) isolation, enrichment and separation
of the CD34+ cell population
CD34+ cells for ex vivo differentiation were enriched from bone
marrow (BM) of a patient with CML and, for comparison, also from
PBSCs of two patients with lymphoma undergoing autologous trans-
plantation and from two healthy donors. HSCs of lymphoma patients
and of healthy donors were taken from the leukapheresis product of
peripheral blood (PBSC graft) after recombinant granulocyte-colony
stimulating factor (rhG-CSF) (Filgrastim; Inc., Amgen, USA) adminis-
tration. Approximately 50 ml of bone marrow were obtained from a
patient with CML in complete hematological remission during the
collection of the back-up graft. Leukapheresis products were enriched
for CD34+ cells as described in the Supplement.
2.5. Stem cells expansion and differentiation
Two different systems were used for the expansion of CD34+ cells.
The ﬁrst expansion system consisted of Iscove's modiﬁed Dulbecco's
medium (IMDM; Sigma-Aldrich, USA) completed with 10% FCS
(Sigma-Aldrich, USA). The second system contained serum-free ex-
pansion medium (SFEM) (StemCell Technologies, Inc., Vancouver,
Canada) without FCS. Both types of media were completed with
100 ng/ml of rhG-CSF (Filgrastim, Inc., USA) and a mixture of recom-
binant human cytokines (CC100; StemCell Technologies, Inc., Canada)
containing 100 ng/ml of stem cell factor (SCF), 20 ng/ml of interleukin-3
(IL-3), 20 ng/ml of interleukin 6 (IL-6) and 100 ng/ml of stem cell tyro-
sine kinase-1 ligand (Flt-3-L). The initial concentration of CD34+ cells
was 2×104/ml in both types of systems. Cells were cultured for
21 days and counted in two-day intervals using an automatic cell coun-
ter (Abbott, USA) to determine the absolute leukocyte count in the sam-
ples. The culture medium was half exchanged every two days, and its
volume was adjusted to keep the cell concentration below 1×106/ml
in order to prevent cell overgrowth. A constant concentration of cyto-
kines was maintained. Samples of 2×105 cells were taken in two-day
intervals from the 6th day for the immunodetection of chromatin struc-
ture markers and DSB repair proteins. The vitality of growing cells was
assessed regularly by a LIVE/DEAD® Viability/Cytotoxicity Kit (Molecu-
lar Probes, Eugene,USA).
2.6. Flow cytometry
The phenotype of growing cellswas analyzed after 14 and 21 days of
culture, and the expression of CD34 antigen was followed every 2 days
on a Cytomics FC500 cytometer (Beckman-Coulter, USA). Number of
cells taken for these measurements was 1×106 in all samples. The
myeloid lineage speciﬁc antigens CD33, CD14 and CD16 were detectedEI (D, E) detected by immunoﬂuorescence during ex vivo differentiation of CD34+ cells
blue, TOPRO3) represent the most progressive fraction of cells at the given time of the
i by day 12. cMYC expression was stopped from day 10. Dimethylated histone was de-
donor; but its level decreased considerably from day 12. (B, C) Histograms of the inte-
+ cells through granulocytes. IOD was measured as described in Section 2.8 for 80–130
ed. All values are expressed as mean standard deviation (s.d.) of (n) number nuclei in
nuclei present on slides for speciﬁc times of differentiation. These differences are likely
t difference of results relative to the values obtained for day 6 was calculated using the
entiation process. The histograms (E) present relation between the content of MNEI in
l slice (0.2 μm thin) through the cells; the mean was calculated from about 100 cells in
the total cellular value for each cell separately. The level of MNEI in the cytoplasm was
value from day 14. RGB channels were nonlinearly increased by the Photoshop curves
Fig. 4. Changes in chromatin structure of mature neutrophils after short exposure to hypotonic treatment. Freshly isolated mature neutrophils of a healthy donor were incubated in
0.5× PBS for 10 min and then immediately submerged to 4% paraformaldehyde for ﬁxation. Chromatin relaxation in neutrophils obtained by this treatment enabled positive
immunodetection of histone H3K9me2 (lower range of images). In neutrophils that were immediately ﬁxed after isolation, the immunodetection of this antigen was negative
(upper range of images).
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PE-Cy5 (Becton-Dickinson, USA; Caltag Lab, USA).
2.7. Cell ﬁxation and immunostaining
Cells harvested at different time intervals from the growing cul-
ture and freshly isolated granulocytes from the peripheral blood
were processed as described earlier [13] and in the Supplement.
2.8. Fluorescence microscopy
Imageswere obtainedwith a high-resolution Leica DMRXA confocal
cytometer (Leica, Wetzlar, Germany) described in [29,30], equipped
with a CSU-10a confocal unit (Yokogawa, Japan), a CoolSnap HQ
charged-coupled device camera (Photometrix, Melbourne, Australia)
and an Ar-Kr laser Inova 70C Spectrum (Coherent, Hilton SA, Australia).
The oil immersion Plan Fluotar objective (100×/NA1.3)was used. Forty
optical sections at 0.2 μm steps were acquired for each nucleus using
the software FISH 2.0 [29,30] at the constant temperature of 26 °C.
The exposition time and dynamic range of the camera in the red,
green and blue channels were adjusted to the same values for all slides
to obtain quantitatively comparable images. Integrated optical density
(IOD) in red or green color channels was measured using the image
analysis software Image-Pro Plus, version 5.1.2.59 (Media Cybernetics,
Inc., MA, USA). IOD registers average intensity per measured object.
It wasmeasured in the central, i.e., 20th slice (0.2 μm thick), through
the cell nucleus. At least 50 nuclei were scored for the measure-
ments of speciﬁc antibodies IOD. The statistical signiﬁcance (P) of
the values obtained during the differentiation relative to the values
on day 6 was determined according to the normal distribution by
the Student t-test.
2.9. RT-PCR
The total RNA was isolated from granulocytes and mononuclear
cells by High Pure RNA Isolation Kit (Roche). 106 cells of each typewere used. cDNA synthesis was performed using Transcriptor High
Fidelity cDNA Synthesis Kit with oligo (dT)18 as a primer (Roche).
PCR ampliﬁcation was carried out using HotStarTaq Master Mix Kit
(Qiagen) with speciﬁc primers listed in the Supplement.
2.10. Protein extraction, gel electrophoresis and western blotting
Protein extraction, gel electrophoresis and western blotting were
done according to the standard procedures, as described in the
Supplement.
2.11. Activation of neutrophils by phorbol 12-myristate 13-acetate to
generate neutrophil extracellular traps
Brinkmann et al. [23] disclosed the capacity of mature neutrophils to
release chromatin and proteins from cytoplasmic granules to formextra-
cellular ﬁbers (NETs) that capture and kill microorganisms. This capacity
of neutrophils can be stimulated not only by pathogenicmicroorganisms
but also by alternative stimuli [26,28], the most potent of which is
phorbol 12-myristate 13-acetate (PMA). We used PMA to detect the ca-
pability of NETs formation by AML neutrophils that are not completely
mature, express HP1γ protein and have immunodetectable H3K9me2.
Granulocytes were isolated from the peripheral blood of 2 healthy
donors and 5 AML patients after elimination of erythrocytes using
Ficoll-Hypacque centrifugation gradient. Freshly isolated neutrophils
were resuspended in RPM1 medium containing 2% of FCS to 1×106
cells/ml. 200 μl of this cell suspensionwas seeded to a positively charged
microscopic slide and incubated for 1 h in CO2 incubator at 37°C. Then,
4 ml of 21 nM PMA or 10,5 nM PMA in RPMI with 2% FCS were added
to cells attached to the slides to obtain the ﬁnal 20 nM or 10 nM concen-
tration of PMA. Cells were incubated in these media for 150 min and
240 min in a CO2 incubator at 370C before ﬁxation in 4% paraformalde-
hyde for 10 min. Cells were then washed 3 times in PBS, permeabilized
in PBS containing 0.2% Triton X-100 and immunostained with anti-
histone H2B antibody from Millipore as described in Supplement.
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Granulocytes isolated from peripheral blood of 2 healthy donors
were resuspended in PBS to 1×106 cell/ml. 200 μl of this cell suspen-
sion were seeded to a microscopic slide and incubated for 30 min in a
CO2 incubator at 37 °C. Next, 4 ml of 0.525× PBS were added and cells
were incubated in this low-salt (150 mOsm) medium (0.5× PBS) for
10 min, ﬁxed in 4% paraformaldehyde for 10 min, permeabilized and
immunostained with anti-histone H3K9me2 antibody (Upstate). (Nor-
mal culture medium or 1× PBS have the osmolarity of 300 mOsm).
3. Results
3.1. Purity of the CD34+ cells
To analyze changes in chromatin structure during the CD34+ cells
differentiation into granulocytes and the ability of CD34+ cells isolat-
ed from CML patients to differentiate (in the presence of the BCR/ABL
translocation), CD34+ cells were isolated, differentiated ex vivo, and
immunologically analyzed for the expression of speciﬁc surface anti-
gens and chromatin structure determining proteins. The purity of
CD34+ cells from bone marrow is usually lower than the purity of
cells obtained from a PBSC graft after single-step separation. There-
fore, the bone marrow cells were puriﬁed in a two-step procedure.
The average purity of the enriched CD34+ cell fraction from PBSC
grafts was 94% and that of BM of a CML patient was 92% (Fig. 1A).
The PCR analysis in combination with FISH method conﬁrmed theFig. 5. Presence of chromatin structure markers and DSB repair proteins in nuclei of blood c
sion of γH2AX and repair proteins in human lymphocytes and neutrophil granulocytes iso
There are neither repair proteins nor γH2AX in irradiated mature neutrophils contrary to ir
myelocytes and neutrophils of peripheral blood of AML patients at the time of the disease dia
neutrophils of the G1 group of AML patients contrary to those of the G2 group. (C) Immun
isolated from the blood of AML patients P1 (group1) and P2 (group2) before and after the
PI. While all detected proteins were found in lymphocytes, they were not found in neutroph
of the group 2 represented by P2 after the treatment. Chromatin was counterstained with T
order to allow the ﬁgure printing.presence of BCR/ABL translocation in 70% of enriched CD34+ cells of
a CML patient.3.2. Ex vivo cell expansion and differentiation of healthy and CML blood
stem cells
Cells from all samples expanded much more efﬁciently in the
SFEM medium without than with FCS in IMDM (Figure S1). Cells of
a CML patient expanded approximately 876× in serum free medium
and only 96× in a medium supplemented with FCS. Cells from PBSC
graft of a healthy donor expanded 39× in serum free medium and
7× in the medium supplemented with FCS. Massive expansion of leu-
kemia cells from a CML patient in SFEM medium was about 20 times
higher than the expansion of cells from a healthy PBSC in this medi-
um and about 13 times higher in the medium completed with FCS.
The lower expansion of both cell types in IMDMmedium containing
10% FCS could be, probably due to amore rapid cell differentiation, indi-
cating that there are some, not yet known cytokines in FCS that are fa-
vorable for terminal granulocyte differentiation and maturation and
were not added into the system. Very similar results were obtained
with stem cells of different donors in repeated experiments. More
rapid differentiation of stem cells in IMDM medium completed with
FCS was manifested by more rapid loss of CD34 antigen (Fig. 1 Bi, Ci)
at both types of donors and also by earlier disappearance of HP1γ pro-
tein and later accumulation of MNEI in cell nuclei of stem cells of a CML
patient during ex vivo differentiation (Fig. 3D, Figure S2).ells isolated from healthy donors and AML patients. (A) The comparison of the expres-
lated from the blood of healthy donors and irradiated with the dose of 3 Gy of γ-rays.
radiated lymphocytes. (B) HP1α, β, γ and H3K9me2 immunodetected in lymphocytes,
gnosis. HP1 proteins and H3K9me2 are present in lymphocytes however they are not in
odetection of γH2AX and repair proteins in γ-irradiated lymphocytes and neutrophils
leukemia treatment. The cells were irradiated with 3 Gy of γ-rays and ﬁxed 30 min
ils of the group 1 patients, represented by P1, before the treatment and in neutrophils
OPRO-3. RGB channels were nonlinearly increased by the Photoshop curves function in
774 E. Lukášová et al. / Biochimica et Biophysica Acta 1833 (2013) 767–779The rate of differentiation characterized by the loss of CD34 anti-
gen was higher for stem cells from the CML donor (Fig. 1 Bi) com-
pared to that for PBSC (Fig. 1 Ci) of healthy donors in both types of
media. A “timetable” summarizing the changes in antigen expression
during the cell differentiation is displayed and compared with
changes in chromatin structure and cell morphology on Fig. 1D.
CD34 antigen almost disappear from cells of PBSC cultured in
serum-free and serum-supplemented media at day 12 and the day
14 from cells of a CML donor (Fig. 1 Bi, Ci, D) and the disappearance
of CD34 antigen is accompanied by the increase of cells expressing
antigens characteristic of myeloid differentiation (CD33dim+, CD13+
and CD16+). The number of cells expressing these antigens increased,
and, on day 21, some 80% of cells from the BM of a CML patients and
the PBSC of a healthy donor were expressing CD33dim+, 70%–80%
expressed CD13+ and 50%–60% expressed CD16+ in both culture sys-
tems (Fig. 1 Bii, Cii, D). Vitality of cells in all systems was above 90%
from the beginning to the end of the culture process.3.3. Changes of HP1, MNEI and H3K9me2 during stem cell differentiation
Stem cells express CD34 antigen, all HP1 proteins, cMYC and
H3K9me2 (Fig. 2). These proteins were successively eliminated during
ex vivo differentiation that was accompanied also by changes in the
shape of cell nuclei. The rate of differentiation was not the same for all
cells in the culture, as shownbydifferences in the nuclear shape and dif-
ferent levels of detected proteins at the appropriate time of cell exami-
nation (Fig. 3A, B, C, D). The homogeneity of cells increased with the
time of differentiation and was higher in the presence of FCS. Many
banded cells were already present by the 8th day of the process
(Fig. 1D). The changes in the shape of the nuclei were accompanied
by a decrease in the level of HPl proteins and H3K9me2 signal on the
one hand (Fig. 1D, 3A, B, C) and by an increased nuclear relocation of
MNEI on the other (Fig. 1D, 3D, E). Cells expressingHP1α andHP1βpro-
teins disappeared completely by the 12th day, cells with HP1γ by the
10th day of the differentiation and the level of MNEI in the nucleus
was higher than in the cytoplasm from the 6th day (Fig. 1D, 3D, E);
from the 14th day and later, this protein was observed predominantlyFig. 6. Transcription activity (RT-PCR) of HP1β, HP1γ and selected DSB repair genes in lymp
group 1 and 2). (A, C) Transcription activity before and after the treatment, respectively. (B,
treatment.in the nucleus (Fig. 1D, 3D, E). The disappearance of HP1 proteins was
correlated with the appearance of higher number segmented nuclei of
neutrophils (Fig. 1D). Importantly, the differentiationprocesswas not sig-
niﬁcantly inﬂuenced by the origin of CD34+ cells (healthy donor, BCR/
ABL translocation or NHL patient), despite the H3K9me2 signal persisted
in neutrophils coming from theCD34+ cells of the CMLpatient somedays
longer (from16th to 18th day) than in the healthy andNHL cells. To show
that inaccessibility of H3K9me2 for immunodetection is caused by a
tighter chromatin condensation during the differentiation of CD34+
cells to granulocytes, we exposed the granulocytes isolated from periph-
eral blood of healthy donors to a short (10 min) incubation in a hypotonic
solution of 0.5× PBS before ﬁxation. Chromatin structure of granulocytes
exposed to this lower-salt solution became more relaxed enabling
H3K9me2 detection (Fig. 4).
It thus appears that there are coordinated consecutive changes of
heterochromatin factors during the granulocyte differentiation process
that include cessation of protein expression (HP1), cytoplasm-nuclear
relocation (MNEI) and protection of antigenic epitopes due to chroma-
tin condensation (H3K9me2).3.4. Capacity of white blood cells for DDR induced by γ-rays
Next, we analyzed how changes in chromatin structure established
in terminally differentiated granulocytes are reﬂected in their functions,
andwhether there are somedifferences betweenmature terminally dif-
ferentiated granulocytes obtained from healthy donors and immature
granulocytes of AML patients. Since DNA repair was reported to be ac-
tive in majority of cell types, we followed the DDR induced by DSBs
that are the most serious DNA lesions. Granulocytes and mononuclear
cells (lymphocytes and monocytes) isolated from the peripheral blood
of healthy donors were irradiated with 3 Gy of γ-rays and formation
of IRIF foci at the sites of DSBs was followed by immunodetection
30 min post-irradiation (PI). While in lymphocytes and monocytes
(Fig. 5A) as well as in stem cells (not shown), the IRIFs appeared very
soon after DSB induction and their colocalization with different repair
proteins was observed, neither the IRIFs nor the repair proteins were
detected in mature neutrophils of healthy donors (Fig. 5A). Thesehocytes and granulocytes of a healthy donor, AML patients P1 and P2 (representing the
D) Levels (WB) of HP1β and HP1γ and some repair proteins before (B) and after (D) the
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to mononuclear cells and myelocytes isolated from the peripheral
blood of AML patients before the treatment and incompletely differen-
tiatedAMLneutrophils (Fig. 5B, C). The presence of HP1 proteins in neu-
trophils of some AML patients made us to divide them into groups for
further analyses: While the neutrophils of the group 1 (G1) AML pa-
tients did not present any HP1 proteins similarly as the healthy mature
neutrophils, those of the group 2 (G2) expressed small amount of HP1
proteins even if they had multi-lobed nuclei, typical for mature neutro-
phils (Fig. 5B). The cells of G2 patients expressed also repair proteins and
phosphorylated H2AX after γ-irradiation; however the colocalization of
γH2AX with repair proteins was rare 30 min post-irradiation (PI)
(Fig. 5C). The expression of HP1γ, HP1β as well as repair proteins after
irradiation thus represent marks of incompletely mature granulocytes.
The absence of the repair proteins in the nuclei of terminally differenti-
ated neutrophils (from healthy donors and G1-patients) was consistent
with missing of the corresponding gene transcription detected by
RT-PCR andwestern blotting (Fig. 6 A, B). The exceptionwas the expres-
sion of small amount of Nibrin (NBS1) in irradiated terminally differen-
tiated granulocytes of healthy donors and G1 patients.Fig. 7. Mature neutrophils isolated from healthy donors release extracellular traps (NETs)
neutrophils were incubated in PMA (20 nM) for 2.5 h at 37 °C before ﬁxation in paraformaThe level of granulocytic maturation in the peripheral blood was
followed in detail at 1 patient (P1) of the group 1 and one of the
group 2 (P2) again 10 month after the beginning of leukemia treat-
ment. At this time, the amount of WBC of P1 was almost normal,
(3.41×109/L), however with only 1.33×109/L of neutrophils
(presenting 39% of WBC). The level of P2 WBC was completely nor-
mal (8.8 x 109/L with 62.8% of neutrophils). The neutrophils of the
latter patient were entirely mature; they expressed none of HP1
proteins, did not form γH2AX foci and expressed none of repair pro-
teins after γ-radiation. (Fig. 5C, 6C). On the other hand, about 50% of
neutrophils of the P1 were not mature. Many of them were in the
stage of band cells. Both, the band and segmented cells expressed
HP1 proteins, detected in the nuclei by speciﬁc antibodies (not
shown). The activity of genes coding for HP1 isoforms and repair
proteins detected by RT-PCR in extracts from granulocytes signiﬁ-
cantly contrasted for P1 and P2 after the treatment (Fig. 6C).
RT-PCR showed active mRNA expression of HP1β and HP1γ and
low expression of genes for DNA repair proteins in case of P1, how-
ever none of these genes were expressed in P2 granulocytes. In spite
of low expression of several repair protein genes (MDC1, 53BP,after activation with phorbol 12-myristate 13-acetate (PMA). Freshly isolated mature
ldehyde and immunodetection of histone H2B.
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were not found by immunodetection on cell nuclei (Fig. 5C, 6D);
however, γH2AX foci marking regions of DSB were detected in the
P1 nuclei after irradiation (Fig. 5C). Their number was smaller as
compared with the lymphocytes irradiated with the same dose.
In some cases when the treatment of leukemia at patients of the
group 2 lead to the attainment of normal mature granulocytes, this sit-
uation was not stable and the patients had to undergo further consoli-
dation treatments. Therefore, we conclude that only the treatment of
AML that removes the cells with causal mutations and simultaneously
leads to persistent granulocyte maturation could effectively prevent
AML relapse. The state of granulocyte maturation was followed for pa-
tients of the G1 and G2 groups for additional 10 to 19 months by immu-
nological detection of HP1β andHP1γ expression. Allﬁve patients of the
G2 had normal number of white blood cells and neutrophils did not
show the marks of immature cells. Two patients of this group were ob-
served after the stem cells allogenic transplantation. All three patients
of the group 1 underwent at least one additional consolidation treat-
ment during this time, however even though they have a normal num-
ber of white blood cells at present, their neutrophils contain HP1
proteins indicating an incomplete differentiation.
3.5. The incomplete maturation of AML neutrophils negatively affects the
function of these cells to form neutrophil extracellular traps (NETs)
The ability to release chromatin NETs upon incubation with PMA
was detected with granulocytes from 2 healthy donors (Fig. 7) and
5 AML patients (Fig. 8). Neutrophils of two of them expressed HP1γ
in about 43% cells; one patient had HP1γ in about 70% of neutrophils,
and two other expressed it in 90% and 94% neutrophils. The neutro-
phils of the last two patients did not respond to activation with
PMA used at two different concentrations (10 nM and 20 nM) for
2.5 h and 4 h. The NETs were not found in any neutrophils among
about 2×105 cells ﬁxed on the microscopic slide and expressing
HP1γ protein in about 90% of cells. The similar results were also
obtained with neutrophils expressing HP1γ protein in about 70%
cells. Nuclei of majority of these cells preserved the shape and struc-
ture of chromatin, (Fig. 8C), while at mature neutrophils exposed to
20 nM PMA for 4 h., the majority of nuclei lost their lobular shape, ex-
panded and released chromatin NETs into the extracellular space
(Fig. 8A).
The ability to release NETs and corresponding changes of chroma-
tin structure were also observed in neutrophils, where the expression
of HP1γ was found in about 40–43% of the cells (Fig. 8B). These re-
sults suggest that remodeling of chromatin structure during neutro-
phil differentiation enable these cells to rapidly react to pathogenic
microbes in a body by releasing chromatin to extracellular space
and forming NETs for capture and killing these microbes and thus
exert the basic function of granulocytes in ﬁghting bacterial infec-
tions. However, when the process of differentiation is not completed
and neutrophils continue to express HP1 proteins, their capability to
release chromatin NETs is precluded.
4. Discussion
In this work, the consequent changes of chromatin structure dur-
ing differentiation of normal and leukemia blood progenitors to
granulocytes were followed and the capability of differentiated cells
to repair DNA DSB was analyzed. We show that heterochromatin epi-
genetic markers change substantially during the ex vivo differentia-
tion of CD34+ cells. These changes consist of the progressive
disappearing of HP1 proteins from differentiating neutrophils, inac-
cessibility of H3K9me2 for immunodetection, and nuclear accumula-
tion of a nucleocytoplasmic serpin MNEI (Figs. 1, 3D, E). The complete
absence of all three heterochromatin proteins HP1 isoforms from dif-
ferentiated HSCs CD34+ is in excellent agreement with our previousstudy showing that the loss of these epigenetic markers distinguishes
mature granulocytes from other human differentiated cells [13].
In order to determine the differences in the behavior of normal
and leukemic cells during the differentiation process, dynamic
changes of chromatin structure were followed for CD34+ cells isolat-
ed from the peripheral blood of healthy and NHL donors and from
bone marrow of a CML patient in chronic phase and after treatment
with Glivec (while still preserving BCR/ABL translocation in the ma-
jority of cells). Changes of chromatin markers during cell differentia-
tion were followed by in situ immunodetection as it is more favorable
than “averaging” methods working with cell lysates for several rea-
sons: It is applicable for a low number of cells (very important in
case of stem cells) and as already mentioned, provides reliable infor-
mation about the expression of antigens in individual cells during
their differentiation and thus precludes “averaging” of results typical
for western blotting and RT-PCR. It is really very important in this
case due to the differences in the progress of differentiation between
individual cells. By maintaining the same conditions in all experi-
ments, we observed that the changes of studied markers during dif-
ferentiation were not inﬂuenced by the origin of the CD34+ cells
and that CD34+ cells can differentiate in mature granulocytes ex
vivo, even in the presence of BCR/ABL translocation (Fig. 3). It
means that the negative inﬂuence of the translocated BCR/ABL tyro-
sine kinase can be overcome by speciﬁc cytokines ex vivo.
In parallel with altering expression of surface antigens and changing
morphology of the nuclei during differentiation, we observed several
changes of higher-order chromatin structure. Soon after stopping prolif-
eration, HP1 proteins disappear, followed by almost complete relocation
of MNEI from the cytoplasm to the nucleus (Fig. 3D). Simultaneously,
the accessibility of H3K9me2 for immunodetection decreases (Fig. 3A).
Association of MNEI with condensed nuclear chromatin after the elimi-
nation of HP1 indicates that this protein could replace HP1 in chromatin
condensation, similar to the homologous serpin MENT in chicken
granulocytes [9,15,31].
It was shown recently that nuclear MNEI plays a role in maintaining
heterochromatin compactness in neutrophils preventing premature for-
mation of NETs [17]. Our results showing that the mature granulocytes
accumulating nuclear MNEI have inhibited DDR further suggest that re-
placing HP1 with MNEI might be associated with DDR inhibition.
The mechanistic link between the HP1 disappearance from chro-
matin during terminal differentiation of human neutrophils, its possi-
ble replacement by MNEI and chromatin condensation remains to be
examined. Nevertheless, our results indicate that the timing and ex-
tent of HP1 loss, nuclear accumulation of MNEI, and inaccessibility
of H3Kme2 reﬂect the level of chromatin compaction and, likely, dif-
ferentiation. It follows from these results that there is a coordinated
temporal order of changes in chromatin proteins and structure and
that these changes are intimately linked with one of the basic func-
tions of neutrophils, the formation of extracellular NETs, in which
chromatin serves as the principal tool.
It thus appears that the purpose of the above mentioned changes
in chromatin structure during differentiation is to enable the unique
function of neutrophils in immune defence. The tightly condensed
chromatin and gene repression in terminally differentiated neutro-
phils must be rapidly reversed upon their activation by microbial in-
fection to allow increased changes in gene expression [32–34] and
chromatin relaxation into extracellular ﬁbers NETs to kill bacteria
[23]. The rapid and extensive changes in gene expression and chro-
matin relaxation in neutrophils are unique phenomena among the
terminally differentiated cells. We show in this work, that the chro-
matin condensation in mature neutrophils in absence of HP1 is
tighter than in its presence as indicted by the low accessibility of
H3K9me2 for immunodetection. The fact that a short exposure of
the neutrophils to hypotonic conditions makes the N-tails of histone
H3 accessible to immunodetection (Fig. 4) shows that the level of
H3K9me2 remains high in these cells and that this high chromatin
Fig. 8. Immature neutrophils expressing HP1γ do not form NETs after activation with PMA. Formation of nets was observed in peripheral neutrophils of the AML patients 1 and 2
expressing HP1γ in about 43% of these cells. No NETs were released by neutrophils of the AML patients 3 and 4, that expressed HP1γ in 90% and 93% of cells.
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for protection of H3K9me2 in mature granulocytes.
This tight chromatin condensation can be abruptly reversed
by concerted action of peptidylarginine deaminase catalyzing his-
tone citrullination and unfolding of chromatin higher-order struc-
ture [35] and by speciﬁc proteases (such as neutrophil elastase)
translocating into the nuclei after their release from granules and
causing large-scale digestion of histones [36]. MNEI which is a spe-
ciﬁc inhibitor of neutrophil elastase [37] may fulﬁll its function inprotecting chromatin from decondensation by promoting chroma-
tin higher-order folding and simultaneously inhibiting the prote-
ases leaking into the nucleus prior to massive NET activation.
The short lifespan of neutrophils and speciﬁc role of their chroma-
tin in forming NETs seem to be the reasons for silencing of genes par-
ticipating in DNA double-strand break repair in mature neutrophils as
we show in this work (Fig. 6). Obviously, the conformational transi-
tion of chromatin during NET formation does not require the integrity
of genome and therefore DSBs need not to be repaired. Importantly,
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gered by mutations in some genes and we show in this work that
these immature cells do not have the ability to release chromatin
into extracellular space and form the NETs. This may have a direct im-
pact on the ability of AML patients in remission to ﬁght bacterial in-
fection. Bacterial and fungal infections are an important cause of
mortality during AML therapy [38,39]. Different genetic changes in-
ducing AML have apparently a crucial inﬂuence on progress and cur-
ability of the disease. At present, not all genetic mutations leading to
AML (and their impact on granulocytic differentiation) are known.
Some patients have mutation in one or more genes that occur fre-
quently in AML (for ex. FLT3, c-KIT, RAS, NPM1, translocation AML1/
ETO); nevertheless, the sequencing of AML genome showed that leu-
kemia cells also contained acquired mutations in several genes that
had not previously been associated with the disease [40]. Therefore
the relationship between the clinical parameters of successful treat-
ment (normal level of white blood cells, etc.), markers of complete
maturation of granulocytes suggested in this work (including the
ability to express HP1 and form chromatin NETs) and speciﬁc genetic
changes should be studied in complex to disclose the cause of incom-
plete granulocytic maturation during the treatment. We believe that
successful elucidation of the important issue why consolidation ther-
apy does in some cases lead to attainment of mature granulocytes and
in other cases does not, could make the leukemia treatment more
efﬁcient.
5. Conclusions
We show in this work that proteins expressed in human blood
stem cells (e.g. CD34, all HP1, cMYC) are successively eliminated dur-
ing ex vivo differentiation that is accompanied by changes in the
shape of cell nuclei, chromatin condensation, and accumulation of
the MNEI protein in the nuclei. Terminally differentiated granulocytes
loss their ability to recognize and repair DNA damage but acquire an-
other function — creation of chromatin extracellular traps (NETs) as a
response to infection. The incompletely differentiated granulocytes of
AML patients expressing HP1 proteins behave differently from the
mature ones. When irradiated with ionizing radiation, they activate
the DDR. The presence of the DDRmarkers in nuclei of immature neu-
trophils shows that these cells are not equivalent to mature cells. One
of the most important consequences of the incomplete maturation of
these cells is the loss of their natural function to release NETs to cap-
ture and kill infecting microbes. Importantly, AML treatment does not
always lead to complete maturation of granulocytes, even if it re-
stores the level of total blood cells including granulocytes to the nor-
mal values. We suggest detection of HP1 proteins in peripheral
granulocytes of AML patients as a very sensitive indicator of their suc-
cessful maturation as well as functionality after the treatment.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.12.012.
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